Sanger Institute-founded PetMedix is working on antibodies for dogs and cats based on an immune system discovery model that will adapt and extend earlier human health research.

Wisconsin Alumni Research Foundation has set up a pre-clinical drug discovery operation called Warf Therapeutics to help support biomedical projects.

Intel Capital-backed online pharmacy 1mg is in the process of raising $70m in funding, with International Finance Corporation expected to contribute.

GV and Alexandria Venture Investments have taken part in a $191m funding round to launch Maze Therapeutics with scientific co-founders from multiple universities such as Harvard and Stanford.

University of Virginia spectroscopy spinout BrightSpec has added series B capital from investors including the university's seed fund to an earlier $1.5m sum raised in 2015.

The UC Berkeley-founded MRI scanner technology spinout graduated from the SkyDeck accelerator in 2018 and has now announced its inaugural round of funding.

Karolinska Institute’s oncology spinout Aprea Therapeutics has received a $5.7m series C extension adding to an initial $56.8m close in November 2018 that featured Karolinska Development.

Praktikertjänst-backed oncology company Aprea has received a $5.7m series C extension adding to an initial $56.8m close in November 2018 that featured Karolinska Development.

Rabo Ventures has co-led the artificial intelligence-based medical imaging technology developer's $11.3m series A alongside Inkef Capital.

Satt Sud-Est has licensed Yukin Therapeutics to commercialise patents originating from several French institutions on the back of inventions from regional research hub Canceropôle Provence-Alpes-Côte d'Azur.